Andrew Dippel

Andrew Dippel, PhD, is an Associate Principal Scientist in Biologics Engineering at AstraZeneca, where they manage a small team supporting antibody lead discovery and optimization efforts. Previously, they served as a Senior Scientist in Bioscience at AstraZeneca, focusing on lead discovery and optimization across various therapy areas. Andrew earned a PhD in Chemical Biology from the University of California, Berkeley, where they developed innovative biosensor systems and co-authored multiple peer-reviewed publications. Their research experience also includes roles at Franklin & Marshall College and the University of Utah, contributing to significant advances in protein engineering and crystallography.